Relative efficacy and safety of simeprevir and telaprevir in treatment-naïve hepatitis C-infected patients in a Japanese population: A Bayesian network meta-analysis-Reference-Cited by-同舟云学术

Relative efficacy and safety of simeprevir and telaprevir in treatment-naïve hepatitis C-infected patients in a Japanese population: A Bayesian network meta-analysis

Published:2015-03-03 Issue:10 Volume:45 Page:E89-E98
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatol Res

Author:

Quigley Joan M.¹,Bryden Peter A.²,Scott David A.¹,Kuwabara Hiroyo³,Cerri Karin⁴⁵

Affiliation:

1. ICON Health Economics; Oxford UK

2. School of Social and Community Medicine, University of Bristol; Bristol UK

3. Janssen Pharmaceutical; Tokyo Japan

4. Janssen Pharmaceutica; Beerse Belgium

5. London School of Economics and Political Sciences; London UK

Funder

Janssen Research and Development

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hepr.12467/fullpdf

Reference43 articles.

1. WHO WHO Hepatitis C Fact Sheet 2011 http://www.who.int/mediacentre/factsheets/fs164/en/

2. Changing trends in hepatitis C infection over the past 50 years in Japan;Chung;Intervirology,2010

3. The burden of illness for patients with viral hepatitis C: evidence from a national survey in Japan;Liu;Value Health,2012

4. Epidemiology of hepatocellular carcinoma in Japan;Umemura;J Gastroenterol,2009

5. Report of the 17th Nationwide Follow-up Survey of Primary Liver Cancer in Japan;Ikai;Hepatol Res,2007

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Science-based Ethnic Bridging in Drug Development; Review of Recent Precedence and Suggested Steps Forward;Current Clinical Pharmacology;2019-12-31

2. An evaluation of the role of fuzzy cognitive maps and Bayesian belief networks in the development of causal knowledge systems;Journal of Intelligent & Fuzzy Systems;2019-09-09

3. A NEW HEALTH TECHNOLOGY ASSESSMENT SYSTEM FOR JAPAN? SIMULATING THE POTENTIAL IMPACT ON THE PRICE OF SIMEPREVIR;International Journal of Technology Assessment in Health Care;2017

4. Personalized Medicine for Hepatitis C Virus;Diagnostic Molecular Pathology;2017

5. Ultra-deep sequencing analysis of resistance-associated variants during retreatment with simeprevir-based triple therapy after failure of telaprevir-based triple therapy in patients with genotype 1 hepatitis C virus infection;Hepatology Research;2016-10-26